|
|
FAculty directory
Back to alphabetical index
Domenico Praticò, MD
Associate Professor, Pharmacology
Telephone: 215-707-9380
Fax: 215-707-7068
Email:
praticod@temple.edu
Department of Pharmacology
MD, University of Rome "La Sapienza", Rome, Italy, 1986
Internship, Hospital of the University of Rome "La Sapienza"
Residency, Hospital of the University of Rome "La Sapienza", 1986-1991
Fellowship, Hemocoagulation, Hospital of the University of Rome "La Sapienza", 1990-1991; Cardiovascular Science, University of Dublin, Ireland, 1992-1994
Return to top
Internal Medicine, University of Rome "La Sapienza", 1991
Return to top
professional affiliations: |
- Society for Neuroscience
- Italian Research Council
- American Federation for Medical Research
- American Heart Association (member of Arteriosclerosis, Thrombosis and Vascular Biology Council)
- New York Academy of Science
- International Academy of Cardiology
Return to top
Dr. Praticò’s research area is clinical pharmacology with a special focus on the cellular and molecular aspects of cell oxidative biology and a particular interest in small molecules such as bioactive oxidized lipids.
This area is very broad and extends to multiple disciplines including aging, cardiovascular diseases as well as neurodegeneration. Our work in the biology of oxidized bioactive lipids has significantly contributed to the current understanding of their importance as biomarkers, mediators of cellular and molecular events involved in the pathogenesis of several clinical conditions, and therapeutic targets for preventing and treating human diseases. In our lab we employ cellular and animal models of human diseases, and in this context particular emphasis is given to the translation of any observation made in these systems into a better understanding of human physiology and pathology. Our group is committed to foster collaborative scientific research of the highest quality, and at the same time to provide outstanding teaching and mentoring for young scientists.
Return to top
book chapters and non pubmed publications: |
Praticò, D., Guzzo, A., Alessandri, C., Bonavita, M.S., Violi, F. Dose-dependent inhibition of platelet aggregation by aspirin in whole blood. Adv. Vasc. Pathol. pp. 665-671 (1990) (chapter).
Praticò, D., Lawson, J.A., FitzGerald, G.A. Cyclooxygenase-dependent formation of 8-iso prostaglandin
F2?
by human platelets. Adv. Prostagl. Thromb. Leuk. Res. 23:229-231 (1995) (chapter).
Praticò, D., Catella F., FitzGerald G.A. Antagonism of platelet integrins and specific thrombin inhibition: the human pharmacology of anti-thrombotic drugs. Atherosclerosis X: 1041-1047; (1995) (chapter).
Reilly, M., Praticò, D., Lanken, P., Delanty, N., Rokach, J., Lawson, J.A., FitzGerald, G.A. Isoprostanes in the assessment of oxidant stress in vivo. In: Molecular and Cellular Basis of Inflammation. Eds. C.N. Serhan and P.A. Ward; pp. 127-139 (1998) (chapter).
Praticò, D., Delanty, N. Oxidative injury of the central nervous system - focus on Alzheimer’s disease. Am. J. Med. 109:577-585 (2000) (review).
Praticò, D. Oxidative imbalance and lipid peroxidation in Alzheimer’s disease. Drug Dev. Res. 56:446-451 (2002) (review).
Praticò, D. Oxidative stress in the development of Alzheimer’s disease and other dementias. In: Alzheimer’s disease: The basics. Eds. R.W. Richter and B. Zoeller Richter. The Humana Press Inc. pp. 33-38 (2003) (chapter).
Praticò, D., Rokach, J., Lawson, J.A., FitzGerald, G.A. F2-isoprostanes as indices of lipid peroxidation in inflammatory diseases. Chem. Phys. Lipids 128:165-171 (2004)(Review).
Rokach, J., Kim, S., Bellone, S., Lawson, J.A., Praticò, D., Powell, W.S., FitzGerald, G.A. Total synthesis of isoprostanes: discovery and quantitation in biological systems. Chem. Phys. Lipids 128:35-56 (2004) (review).
Praticò, D. Alzheimer’s disease and non-steroidal anti-inflammatory drugs: old therapeutic tools with novel mechanisms of action? Curr. Med. Chem. CNS 5: 111-117 (2005) (review).
Praticò, D. Causes and consequences of oxidative stress in neurodegerative diseases. In: Genotype, Proteotype and Phenotype relationships in neurodegenerative diseases. Eds. J. Cummings and Y. Christen. Springer Publisher; pp.37-44 (2005) (chapter).
Cyrus, T., Praticò, D. Antioxidants and chronic cardiovascular diseases: animal studies. In: Antioxidants and Cardiovascular Disease. 2nd Edition. Eds. M.G. Bourassa, J-C Tardif. Springer Publishers; pp. 227-253 (2006) (chapter).
Cyrus, T., Praticò, D. Vitamin E and Atherosclerosis. In The encyclopedia of Vitamin E. Eds.V.R. Preedy and R.R. Watson. CABI Publishing, Wallingford, UK; pp. 623-632 (2006) (chapter).
Cyrus, T., Praticò, D. Vitamin E and Atherosclerosis: Animal and Human trials. In Vitamin E: New Research. Ed. Matthew H. Braunstein. Nova Science Publishers; pp.177-199 (2006) (chapter).
Praticò, D. Antioxidants and endothelium protection. In: Endothelial dysfunction and vascular disease. Eds. R. De Caterina and P. Libby. Blackwell Futura Publishing; pp. 315-322 (2007) (chapter).
de Leon, M.J., Mosconi, L., Blennow, K., De Santi, S., Zinkowski, R., Mehta, P.D., Praticò, D., Tsui, W., Saint Louis, L.A., Sobanska, L., Brys, M., Li, Y., Rich, K., Rinne, J., Rusinek, H. Imaging and CSF studies in the preclinical diagnosis of Alzheimer’s disease. In Imaging and the Aging Brain. Eds. DeLeon MJ, Snider DA, and Federoff H. Blackwell Publishing; pp.114-45.2 (2007) (chapter).
Return to top
Recent Medically Related Publications, Obtained from PubMed (Click on PubMed ID to view abstract)
19798476. van der Giet M, Tölle M, Pratico D, Lufft V, Schuchardt M, Hörl MP, Zidek W, Tietge UJ, Increased type IIA secretory phospholipase A(2) expression contributes to oxidative stress in end-stage renal disease. J Mol Med :()2009 Oct 2
19764861. Praticò D, Dogné JM, Vascular biology of eicosanoids and atherogenesis. Expert Rev Cardiovasc Ther 7:9(1079-89)2009 Sep
19735918. Cyrus T, Ding T, Praticò D, Expression of thromboxane synthase, prostacyclin synthase and thromboxane receptor in atherosclerotic lesions: Correlation with plaque composition. Atherosclerosis :()2009 Aug 13
19542607. Polidori MC, Praticó D, Mangialasche F, Mariani E, Aust O, Anlasik T, Mang N, Pientka L, Stahl W, Sies H, Mecocci P, Nelles G, High Fruit and Vegetable Intake is Positively Correlated with Antioxidant Status and Cognitive Performance in Healthy Subjects. J Alzheimers Dis :()2009 Jun 19
19278942. Pratico D, High-dose B vitamin supplements and Alzheimer disease. JAMA 301:10(1020-1; author reply 1021-2)2009 Mar 11
19265038. Collins AR, Lyon CJ, Xia X, Liu JZ, Tangirala RK, Yin F, Boyadjian R, Bikineyeva A, Praticò D, Harrison DG, Hsueh WA, Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ Res 104:6(e42-54)2009 Mar 27
19221425. Brys M, Glodzik L, Mosconi L, Switalski R, De Santi S, Pirraglia E, Rich K, Kim BC, Mehta P, Zinkowski R, Pratico D, Wallin A, Zetterberg H, Tsui WH, Rusinek H, Blennow K, de Leon MJ, Magnetic resonance imaging improves cerebrospinal fluid biomarkers in the early detection of Alzheimer's disease. J Alzheimers Dis 16:2(351-62)2009 Feb
19220291. Zhao L, Ding T, Cyrus T, Cheng Y, Tian H, Ma M, Falotico R, Praticò D, Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor. Br J Pharmacol 156:5(774-85)2009 Mar
19076432. Praticò D, Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows. Ann N Y Acad Sci 1147:(70-8)2008 Dec
19019188. Mattsson N, Yaong M, Rosengren L, Blennow K, Månsson JE, Andersen O, Zetterberg H, Haghighi S, Zho I, Pratico D, Elevated cerebrospinal fluid levels of prostaglandin E2 and 15-(S)-hydroxyeicosatetraenoic acid in multiple sclerosis. J Intern Med 265:4(459-64)2009 Apr
18983885. Strydom A, Dickinson MJ, Shende S, Pratico D, Walker Z, Oxidative stress and cognitive ability in adults with Down syndrome. Prog Neuropsychopharmacol Biol Psychiatry 33:1(76-80)2009 Feb 1
18838179. Praticò D, Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends Pharmacol Sci 29:12(609-15)2008 Dec
18541983. Connolly J, Siderowf A, Clark CM, Mu D, Pratico D, F2 isoprostane levels in plasma and urine do not support increased lipid peroxidation in cognitively impaired Parkinson disease patients. Cogn Behav Neurol 21:2(83-6)2008 Jun
18514200. Praticò D, Prostanoid and isoprostanoid pathways in atherogenesis. Atherosclerosis 201:1(8-16)2008 Nov
18509095. Ringman JM, Younkin SG, Pratico D, Seltzer W, Cole GM, Geschwind DH, Rodriguez-Agudelo Y, Schaffer B, Fein J, Sokolow S, Rosario ER, Gylys KH, Varpetian A, Medina LD, Cummings JL, Biochemical markers in persons with preclinical familial Alzheimer disease. Neurology 71:2(85-92)2008 Jul 8
18448655. Shineman DW, Zhang B, Leight SN, Pratico D, Lee VM, Thromboxane receptor activation mediates isoprostane-induced increases in amyloid pathology in Tg2576 mice. J Neurosci 28:18(4785-94)2008 Apr 30
18326691. Hadziahmetovic M, Dentchev T, Song Y, Haddad N, He X, Hahn P, Pratico D, Wen R, Harris ZL, Lambris JD, Beard J, Dunaief JL, Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD. Invest Ophthalmol Vis Sci 49:6(2728-36)2008 Jun
18206890. Tang L, Ding T, Praticò D, Additive anti-atherogenic effect of thromboxane receptor antagonism with 12/15lipoxygenase gene disruption in apolipoprotein E-deficient mice. Atherosclerosis 199:2(265-70)2008 Aug
17998412. Firuzi O, Zhuo J, Chinnici CM, Wisniewski T, Praticò D, 5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease. FASEB J 22:4(1169-78)2008 Apr
17994313. de Leon MJ, Mosconi L, Li J, De Santi S, Yao Y, Tsui WH, Pirraglia E, Rich K, Javier E, Brys M, Glodzik L, Switalski R, Saint Louis LA, Pratico D, Longitudinal CSF isoprostane and MRI atrophy in the progression to AD. J Neurol 254:12(1666-75)2007 Dec
Return to top
|
|